Skip to search.
 TSX Up 0.07% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Celgene Corporation (CELG)

-NasdaqGS

122.58 Down 1.06(0.86%) May 24, 4:00PM EDT|After Hours : 122.58 0.00 (0.00%) May 24, 4:20PM EDT

Add to Portfolio
Prev Close:123.64
Open:123.34
Bid:120.80 x 100
Ask:128.35 x 1500
1y Target Est:134.63
Beta:0.92
Next Earnings Date:25-Jul-13CELG Earnings announcement
Day's Range:121.66 - 123.71
52wk Range:58.53 - 131.82
Volume:2,286,520
Avg Vol (3m):3,198,730
Market Cap:51.13B
P/E (ttm):37.29
EPS (ttm):3.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
CELGDown 0.86%51.13B
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.59%11.96B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):17.77
P/S (ttm):9.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :5.75
Quarterly EPS Est (Jun-13) :1.43
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.97

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and immune-inflammatory related diseases in the United States, Europe, and other countries. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback